| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | 0.08 | 0.05 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.05 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.05 |
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.094 | 0.05 |